No Data
Touyun Biotech Expands Into Vegan Food Markets
touyun biotech (01332) has expanded the new application range and space for the production of chlorella, and has started entering the artificial fish, shrimp, and plant milk markets.
Touyun Biotech (01332) announced that on November 20, 2024, its wholly-owned subsidiary shanxi Touyun Biotech...
touyun biotech (01332) issued a total of 0.279 billion share purchase rights.
touyun biotech (01332) announced that as of September 30, 2024, the company, in accordance with the resolutions adopted on June 2, 2022...
TOUYUN BIOTECH: INTERIM REPORT 2024
The performance of touyun biotech (01332.HK) narrowed its losses in the first half to 47.97 million yuan.
touyun biotech (01332.HK) announced its interim performance for the six months ending in June, with revenue recording 73.05 million yuan, a 30% year-on-year decrease. The loss narrowed from 83.95 million yuan in the same period last year to 47.97 million yuan, with a loss per share of 1.71 cents. No interim dividends will be distributed.
Touyun Biotech Group Reports Narrower Half-Year Loss
No Data
No Data